SAT1 and acute lymphoblastic leukemia: These data argue against increased SAT1 activity in ALL [8], while being in line with transcript analyses showing SAT1 downregulation in a B-ALL cohort compared with healthy samples [23], though we cannot exclude potential differences related to post-transcriptional or post-translational mechanisms of regulation occurring at least in a subset of patients.